Initial studies suggest that Retatrutide – a dual activator of gut hormone and GIP receptors – may provide a substantial breakthrough in body management therapies. Unlike existing therapies, the peptide appears to affect hunger and energy expenditure through multiple routes. Despite more investigation is essential, current results spark optimi